TY  - BOOK
ED  - United States.
TI  - Challenges to FDA's ability to monitor and inspect foreign clinical trials
PY  - 2010///
CY  - [Washington, D.C.]
PB  - Department of Health and Human Services, Office of Inspector General
KW  - United States
KW  - Food and Drug Administration
KW  - Auditing
KW  - Clinical trials
KW  - Government policy
KW  - Biologicals
KW  - Testing
KW  - Drugs
N1  - Title from title screen (viewed Aug 9, 2016); "June 2010."; "OEI-01-08-00510."; CRDP Project record; Includes bibliographical references
UR  - http://purl.fdlp.gov/GPO/gpo71045
ER  -